Literature DB >> 23930237

As time goes by.

Roy Yaari, Geri Hall, Helle Brand, Jan Dougherty, Adam S Fleisher, James D Seward, Pierre N Tariot.   

Abstract

Year:  2013        PMID： 23930237      PMCID： PMC3733530          DOI： 10.4088/PCC.13alz01518

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  9 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  In-office mental status testing: a practical guide.

Authors:  D Mungas
Journal:  Geriatrics       Date:  1991-07

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

4.  Prevalence of primitive reflexes and Parkinsonian signs in dementia.

Authors:  K A Links; D Merims; M A Binns; M Freedman; T W Chow
Journal:  Can J Neurol Sci       Date:  2010-09       Impact factor: 2.104

5.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

6.  Smooth-pursuit eye movement--a convenient bedside indicator for evaluating frontal lobe and intellectual function.

Authors:  Kazumasa Sudo; Yasunori Mito; Yasutaka Tajima; Akihisa Matsumoto; Oh Oikawa; Kunio Tashiro
Journal:  In Vivo       Date:  2010 Sep-Oct       Impact factor: 2.155

7.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

Review 8.  Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.

Authors:  Martin R Farlow; Michael L Miller; Vojislav Pejovic
Journal:  Dement Geriatr Cogn Disord       Date:  2008-04-03       Impact factor: 2.959

Review 9.  Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D J Iverson; G S Gronseth; M A Reger; S Classen; R M Dubinsky; M Rizzo
Journal:  Neurology       Date:  2010-04-12       Impact factor: 11.800
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.